| NCT ID | NCT07616830 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assiut University |
| Condition | Stoma Colostomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-06-15 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-06-15 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
* Ileostomy or colostomy is a common surgical procedure used for diverting the lower gastrointestinal content away from distal pathology or anastomotic insufficiency. Once the distal problem has been fixed, the plan is to reverse the stoma. However, the reversal of a stoma is associated with complications, including anastomotic leaks, wound infection, and incisional hernias which can reach up to 33-50%. * The ideal site for a stoma on the abdominal wall depends on several factors, including the patient's anatomy, the type of stoma (colostomy or ileostomy), operative findings, and the patient's preferences. Stomas have traditionally been fashioned through the rectus muscle, away from the midline of the abdomen, and below the umbilicus. * Management of a stoma placed at the center of a long midline laparotomy wound is challenging with the risk of faecal contamination of midline incision. However in many scenarios, the surgeon is left without options rather than to exteriorize the bowel loop through the midline. Moreover, advantages of midline stoma may include: 1. Easy to create and save operative time. 2. Minimize destruction of the anterior abdominal wall (less tissue injury). 3. Eliminate the long-term risk of incisional hernia at the site of previous stoma. Only, few reports assess the outcomes of midline ostomy as a temporary stoma
Eligibility Criteria
Inclusion Criteria: * Patients who will undergo temporary stoma (ileostomy/colostomy) through midline incision. Exclusion Criteria: * Patients with jejunostomy. * Patients with severe sepsis.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07616830 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Stoma Colostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07616830 currently recruiting?
Yes, NCT07616830 is actively recruiting participants. Contact the research team at mohamad_raafat10@yahoo.com for enrollment information.
Where is the NCT07616830 trial being conducted?
This trial is being conducted at Asyut, Egypt.
Who is sponsoring the NCT07616830 clinical trial?
NCT07616830 is sponsored by Assiut University. The trial plans to enroll 30 participants.